GPC3 and depressive symptom measurement: In this study, we provide preclinical evidence that addresses the CPSP and its anxious and depressive consequences using a reproducibly established thalamic hemorrhagic stroke model and investigate the role of SGB in inhibiting HIF-1α/NLRP3 signaling to improve CPSP with comorbid anxiety and depression.